πŸ‡ΊπŸ‡Έ FDA
Patent

US 11959084

Nucleic acid construct

granted A61KA61K2039/5156A61K2039/5158

Quick answer

US patent 11959084 (Nucleic acid construct) held by AUTOLUS LIMITED expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
AUTOLUS LIMITED
Grant date
Tue Apr 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K2039/5156, A61K2039/5158, A61K39/0011